# Gotham Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gotham-therapeutics

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.gothamtx.com
- Total disclosed funding: $54M
- Latest round: Series A (Oct 10, 2018)
- Investors on record: 5

## About

Gotham Therapeutics operates in the iGaming sector, focusing on the development and licensing of innovative online slot games designed to enhance player engagement and provide entertainment options for a global audience.Founded in 2017 and headquartered in New York, US, Gotham Therapeutics specializes in the iGaming industry. The company had one notable funding round, raising USD 54.00 mn in a Series A round on October 10, 2018, with investments from Versant Ventures, Forbion, S.R. One, Celgene, and Alexandria Venture Investments. The CEO, Lee Babiss, leads the company in its strategic pursuits.Gotham Therapeutics operates in the iGaming sector, primarily focusing on online slot games developed by various game providers including Games Global, Spinomenal, Playson, and Hacksaw Gaming. Their offerings include a diverse range of slot games such as "Gold Blitz Ultimate," "Outlaw’s Redemption," "3 Luxor Pots: Hold and Win," "Donut Division," and "Barnyard Megahays Megaways," which feature unique themes and innovative game mechanics designed to enhance player engagement. These products cater to a broad audience of online gamers globally, with specific markets including the United States and various regions in Europe. The company's clientele consists of individual players who engage in online gambling and gaming operators who host these games on their platforms, addressing the entertainment needs of a rapidly growing digital audience.Gotham Therapeutics generates revenue through transactions between game providers and gaming operators, licensing their games to be featured on various online casino platforms. Operators typically pay a fee or a percentage of the revenue generated from the games. Flagship products such as "Gold Blitz Ultimate" and "Outlaw’s Redemption" are offered under contractual agreements that detail the revenue-sharing framework between Gotham Therapeutics and its partners.Gotham Therapeutics plans to utilize the recent USD 54.00 mn funding raised in October 2018 for further product development and market expansion. The company is designing new online slot games set to launch in the coming years, targeting the rapidly growing markets in Europe and expanding its presence further in the United States by 2024.

## Funding rounds

- Series A, Oct 10, 2018, $54M — Versant Ventures, SR One, Alexandria Venture Investments, Forbion, Celgene

## Investors

- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Forbion (https://capitalatlas.ai/funds/forbion) — Series A
- Celgene — Series A